KNKohji Nishida

Kohji Nishida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kohji Nishida has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Beyond Eye Rubbing: Mechanical Ocular Stimulation Is Highly Prevalent in Keratoconus

    by Shizuka Koh, Ryota Inoue, Damien Gatinel, Kohji Nishida

    Objectives: To investigate current and previous mechanical ocular stimulation behaviors beyond conventional eye rubbing in patients with keratoconus. Methods: This prospective study included Japanese outpatients with a clinical diagnosis of keratoconus in at least one eye. All participants completed a structured investigator-developed questionnaire assessing current and past mechanical ocular stimulation behaviors, followed by face-to-face physician interviews. Questionnaire items included history, reasons, duration, frequency, techniques, and anatomical sites of stimulation. Results: A total of 304 patients were included, with 91.4% reporting mechanical ocular stimulation. These behaviors were typically long-standing (75.9% >10 years) and varied widely in motivation, frequency, methods, and anatomical sites. Ocular itching was the most common trigger (75.9%), although many behaviors were unrelated to itching. Finger pulp (56.1%) and knuckles (48.6%) were commonly used, and the medial canthus was the most commonly involved site (70.1%) ( P <0.05). Pressure-related behaviors, such as eye pressing or massage during fatigue, were reported by approximately one third of patients. Conclusions: The concept of mechanical ocular stimulation provides a more comprehensive framework than eye rubbing for characterizing pressure-related behaviors in patients with keratoconus. Broader assessment of current and past behaviors may improve clinical assessment and patient counseling.

  • Open Access

    An Association between HTRA1 and TGF-β2 in the Vitreous Humor of Patients with Chorioretinal Vascular Diseases

    by Yoko Fukushima, Shizuka Takahashi, Machiko Nakamura, Tatsuya Inoue, Yusuke Fujieda, Toshiyuki Sato, Shingo Noguchi, Motokazu Tsujikawa, Hirokazu Sakaguchi, Kohji Nishida

    Background: The aim of this paper was to investigate the protein concentrations of high-temperature requirement A 1 (HTRA1) and transforming growth factor-β (TGF-β) in the vitreous humor of patients with chorioretinal vascular diseases. Methods: This study measured protein concentrations of HTRA1, TGF-β1−3, and vascular endothelial growth factor A (hereinafter called VEGF) in the vitreous humor from seven eyes of patients with chorioretinal vascular diseases (age-related macular degeneration, diabetic macular edema, and retinal vein occlusion) and six control eyes (idiopathic epiretinal membrane and macular hole). We analyzed the mutual relationship among the protein levels. Results: The protein levels of HTRA1 and VEGF were significantly increased in the chorioretinal vascular disease group compared with the control group (1.57 ± 0.79 ×10−9 mol/mL vs. 0.68 ± 0.79 ×10−9 mol/mL, p = 0.039; 3447.00 ± 3423.47 pg/mL vs. 35.33 ± 79.01 pg/mL, p = 0.046, respectively). TGF-β2 levels were not significantly different between groups (2222.71 ± 1151.25 pg/mL for the chorioretinal vascular disease group vs. 1918.83 ± 744.01 pg/mL for the control group, p = 0.62). The concentration of HTRA1 was strongly associated with TGF-β2 levels in the vitreous humor, independent of VEGF (r = 0.80, p = 0.0010). Conclusions: We revealed that vitreous HTRA1 was increased in patients with chorioretinal vascular diseases and strongly correlated with TGF-β2.


  • Open Access

    Cytomegalovirus-Induced Optic Neuritis Through Cerebrospinal Fluid Viral Transmission in an Immunocompetent Patient: A Case Report

    by Shizuka Takahashi, Noriyasu Hashida, Kazuichi Maruyama, Rina Omura, Rei Sakurai, Takeshi Morimoto, Kohji Nishida


  • Open Access

    Idiopathic Multicentric Castleman Disease Presenting With Hypertensive Choroidopathy: A Case Report

    by Tamami Mimoto, Noriyasu Hashida, Kohji Nishida

    Castleman disease (CD) is a lymphoproliferative disorder and rarely affects ocular tissue. This study aimed to report a case of hypertensive choroidopathy in a patient with Castleman’s disease associated with malignant hypertension. A 39-year-old man visited his local physician with fever, systemic edema, and multiple lymphadenopathies. An inguinal lymph node biopsy indicated CD. One month after the biopsy, the patient noted a blurring of vision. At the time of the initial examination at our hospital, his best-corrected visual acuity (BCVA) was 20/20 in both eyes but there were bilateral multiple Elschnig spots and sprinter hemorrhage at the fundus. Swept-source optical coherence tomography showed intra-retinal fluid, and serous retinal detachment (SRD). Fluorescein angiography revealed multiple punctate hyper fluorescences and indocyanine green angiography showed choroidopathy with increased vascular permeability. A general examination revealed symptoms of cardiac failure and multiple lymphadenopathies. Malignant hypertension with acute glomerulonephritis was diagnosed after a renal biopsy. After antihypertensive treatment, his blood pressure (BP) improved, and the SRD and choroidopathy promptly resolved. Presently, the patient is being followed up without complications. We report a case of hypertensive choroidopathy in a patient with CD associated with malignant hypertension. As a severe elevation in BP can damage choroidal vasculature and lead to vision loss, careful observation and active treatment are necessary.


  • Open Access

    Preliminary demonstration of a novel intraocular lens power calculation: the O formula

    by So Goto, Naoyuki Maeda, Kazuhiko Ohnuma, Tjundewo Lawu, Ryo Kawasaki, Shizuka Koh, Kohji Nishida, Toru Noda

    Purpose: To evaluate the performance of a new formula of intraocular lens (IOL) power calculation (the O formula) based on ray tracing without commonly used parameters, including ultrasound-compatible axial length, keratometry readings, and A-constant. Setting: Tokyo Medical Center, Tokyo, Japan. Design: Retrospective consecutive case series. Methods: 423 eyes (423 patients) implanted with a single-piece, L-loop, acrylic IOL were enrolled. All biometric data for the O formula were obtained by anterior segment swept-source optical coherence tomography (SS-OCT) and SS-OCT–based biometer. The performance of the O formula was compared with those of the Barrett Universal II (BUII) and Kane formulas at 1 month postoperatively. Statistical analysis was applied according to a heteroscedastic test with SD of prediction errors as the main parameter for formula performance. Results: The SD of the O formula (0.426) was statistically significantly lower than that of the BUII formula (0.464, P = .034) but not statistically significantly different from that of the Kane formula (0.433, P = .601). The percentages of patients with refractive prediction errors within ±0.50 diopter (D) and ±1.00 D of the O, BUII, and Kane formulas were 75.4% and 98.6%, 77.1% and 97.9%, and 76.6% and 98.1%, respectively. Conclusions: The O formula, based on ray tracing using SS-OCT–based devices, is one of the promising approaches for IOL power calculation, although additional larger scale studies are needed. It may be used as an alternative in IOL power calculation because of its independence from commonly used parameters.